Atropisomeric 8-arylchromen-4-ones exhibit enantioselective inhibition of the DNA-dependent protein kinase (DNA-PK)

被引：13

作者：

Cano, Celine ^{[1
]}

Golding, Bernard T. ^{[1
]}

Haggerty, Karen ^{[1
]}

Hardcastle, Ian R. ^{[1
]}

Peacock, Marcus ^{[2
]}

Griffin, Roger J. ^{[1
]}

机构：

[1] Univ Newcastle, No Inst Canc Res, Sch Chem, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England

[2] KuDOS Pharmaceut Ltd, Cambridge CB4 0PE, England

来源：

ORGANIC & BIOMOLECULAR CHEMISTRY | 2010年 / 8卷 / 08期

基金：

英国工程与自然科学研究理事会;

关键词：

DIRECTED ORTHO-METALATION; HUMAN TUMOR-CELLS; STRAND BREAK; POTENT; WORTMANNIN; RADIOSENSITIZATION; IDENTIFICATION; DISCOVERY; RADIATION; LY294002;

D O I：

10.1039/b926245h

中图分类号：

O62 [有机化学];

学科分类号：

070303 ; 081704 ;

摘要：

Substitution at the 3-position of the dibenzothiophen-4-yl ring of 8-(dibenzo[b,d]thiophen-4-yl)-2-morpholino-4H-chromen-4-one NU7441, a potent and selective DNA-dependent protein kinase (DNA-PK) inhibitor, with propyl, allyl or methyl enabled the separation by chiral HPLC of atropisomers. This is a consequence of restricted rotation about the dibenzothiophene-chromenone bond. Biological evaluation against DNA-PK of the pairs of atropisomers showed a marked difference in potency, with only one enantiomer being biologically active.

引用

页码：1922 / 1928

页数：7

共 50 条

[1] Potent enantioselective inhibition of DNA-dependent protein kinase (DNA-PK) by atropisomeric chromenone derivatives
Clapham, Kate M.
Rennison, Tommy
Jones, Gavin
Craven, Faye
Bardos, Julia
Golding, Bernard T.
Griffin, Roger J.
Haggerty, Karen
Hardcastle, Ian R.
Thommes, Pia
Ting, Attilla
Cano, Celine
ORGANIC & BIOMOLECULAR CHEMISTRY, 2012, 10 (33) : 6747 - 6757
[2] 8-biarylchromen-4-one inhibitors of the DNA-dependent protein kinase (DNA-PK)
Murr, Marine Desage-El
Cano, Celine
Golding, Bernard T.
Hardcastle, Ian R.
Hummersome, Marc
Frigerio, Mark
Curtin, Nicola J.
Menear, Keith
Richardson, Caroline
Smith, Graeme C. M.
Griffin, Roger J.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (17) : 4885 - 4890
[3] Selective inhibition of the DNA-dependent protein kinase (DNA-PK) by the radiosensitizing agent caffeine
Block, WD
Merkle, D
Meek, K
Lees-Miller, SP
NUCLEIC ACIDS RESEARCH, 2004, 32 (06) : 1967 - 1972
[4] Development of potent inhibitors of the DNA-dependent protein kinase (DNA-PK)
Cano, Celine
Bailey, Chris
Bardos, Julia
Curtin, Nicola
Frigerio, Mark
Golding, Bernard
Hardcastle, Ian
Hummersone, Marc
Menear, Keith
Newell, David
Saravanan, Kappusamy
Shea, K.
Smith, Graeme
Griffin, Roger
CANCER RESEARCH, 2010, 70
[5] Development of potent inhibitors of DNA-dependent protein kinase (DNA-PK)
Barrett, Lauren
Rennison, Tommy
Clapham, Kate M.
Rodriguez-Aristegui, Sonsoles
Bardos, Julia
Curtin, Nicola J.
Dennis, M.
Finlay, Ray
Golding, Bernard T.
Hardcastle, Ian R.
Newell, David R.
Young, Gail
Cano, Celine
Griffin, Roger J.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 245
[6] Development of potent inhibitors of the DNA-dependent protein kinase (DNA-PK)
Cano, Celine
Curtin, Nicola
Hardcastle, Ian
Golding, Bernard
Smith, Graeme
Newell, Herbie
Griffin, Roger
MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)
[7] Development of potent inhibitors of DNA-dependent protein kinase (DNA-PK)
Clapham, K. M.
Rennison, T.
Rodriguez-Aristegui, S.
Bardos, J.
Curtin, N. J.
Golding, B. T.
Hardcastle, I. R.
Newell, D. R.
Cano, C.
Griffin, R. J.
EJC SUPPLEMENTS, 2010, 8 (07): : 140 - 140
[8] DNA-BINDING BY THE THE HUMAN DNA-DEPENDENT PROTEIN-KINASE, DNA-PK
POLTORATSKY, V
MALIK, N
SAMSON, G
LIEBER, M
CARTER, T
FASEB JOURNAL, 1995, 9 (06): : A1394 - A1394
[9] Regulation of the DNA-dependent protein kinase (DNA-PK) activity in eukaryotic cells
Muller, C
Calsou, P
Frit, P
Salles, B
BIOCHIMIE, 1999, 81 (1-2) : 117 - 125
[10] The DNA-dependent protein kinase, DNA-PK: 10 years and no ends in sight
LeesMiller, SP
BIOCHEMISTRY AND CELL BIOLOGY-BIOCHIMIE ET BIOLOGIE CELLULAIRE, 1996, 74 (04): : 503 - 512

← 1 2 3 4 5 →